What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 5 minute read Pharma Industry News AYP-101 could replace Kybella? AMI Pharm’s injectable shows strong Phase 2 results for fat reduction AMI Pharm's AYP-101 delivers strong Phase 2 results in reducing submental fat—find out why it’s being called a game-changer in nonsurgical aesthetics. byPallavi MadhirajuSeptember 1, 2025